Peter Hanna

A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

Glenwood Goss, Hal W. Hirte, Wilson H. Miller et al. · Investigational New Drugs · 2005 · 47 citations

National Cancer Institute, Oncology, Oral Potentially Malignant Disorders +9

Acute Kidney Injury following Enhanced Recovery after Surgery in Patients Undergoing Radical Cystectomy

Peter Hanna, Matt Peterson, Jacob Albersheim et al. · The Journal of Urology · 2020 · 27 citations

Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients?

Peter Hanna, Joseph Zabell, Yasser Osman et al. · World Journal of Urology · 2020 · 26 citations

Enhanced Recovery, Radical Cystectomy, Urology +6

Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy

Jacob Albersheim, Niranjan Sathianathen, Joseph Zabell et al. · The Journal of Urology · 2019 · 22 citations

Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy

Sari Khaleel, Subodh Regmi, Peter Hanna et al. · The Journal of Urology · 2021 · 19 citations